Rani Therapeutics Holdings, Inc.RANIEarnings & Financial Report
Nasdaq
RANI Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-7.3M
Net Profit
$-5.4M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.12
Rani Therapeutics Holdings, Inc. Q3 2025 Financial Summary
Rani Therapeutics Holdings, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-5.4M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-5.4M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
Rani Therapeutics Holdings, Inc. Annual Revenue by Year
Rani Therapeutics Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $1.0M).
| Year | Annual Revenue |
|---|---|
| 2024 | $1.0M |
Income Statement
| Q3 2022 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $1.0M | $172000 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q3 2022 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $108.2M | $53.5M | $43.7M | $43.5M | $36.6M | $24.1M | $16.9M | $10.1M |
| Liabilities | $21.6M | $39.0M | $38.2M | $37.8M | $33.1M | $29.5M | $26.1M | $22.1M |
| Equity | $42.2M | $7.4M | $2.8M | $3.1M | $2.0M | $-3.1M | $-5.6M | $-7.9M |
Cash Flow
| Q3 2022 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-12.2M | $-9.4M | $-9.0M | $-8.4M | $-8.7M | $-8.1M | $-5.8M | $-5.1M |